Anaptysbio (ANAB) Assets Average (2017 - 2025)
Anaptysbio (ANAB) has disclosed Assets Average for 9 consecutive years, with $358.7 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Assets Average fell 26.58% year-over-year to $358.7 million, compared with a TTM value of $358.7 million through Dec 2025, down 26.58%, and an annual FY2025 reading of $424.1 million, down 9.4% over the prior year.
- Assets Average was $358.7 million for Q4 2025 at Anaptysbio, up from $344.2 million in the prior quarter.
- Across five years, Assets Average topped out at $634.1 million in Q1 2022 and bottomed at $344.2 million in Q3 2025.
- Average Assets Average over 5 years is $483.4 million, with a median of $465.1 million recorded in 2023.
- The sharpest move saw Assets Average surged 56.0% in 2022, then fell 26.58% in 2025.
- Year by year, Assets Average stood at $533.7 million in 2021, then increased by 15.13% to $614.4 million in 2022, then decreased by 23.53% to $469.9 million in 2023, then increased by 3.99% to $488.6 million in 2024, then dropped by 26.58% to $358.7 million in 2025.
- Business Quant data shows Assets Average for ANAB at $358.7 million in Q4 2025, $344.2 million in Q3 2025, and $378.7 million in Q2 2025.